Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Bayer | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
NEAT is an observational cohort (Prospective registry of real world data) of patients with coronary and peripheral artery disease in an outopatient setting.
National multicenter registry in Brazil with initial plan of 25 sites from the 5 Brazilian regions. It will be coordinated by HCOR Research Institute which will perform regulatory, data and site management beyond academic leadership.NEAT is an observational cohort (Prospective registry of real world data) of patients with coronary and peripheral artery disease in an outopatient setting with 12 months of follow-up with collection of data at baseline, 6 months and 12 months.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of patients receiving evidence based therapies to reduce cardiovascular risk | DOMAIN 1: Appropriate use of antithrombotic therapy | Baseline |
| Percentage of patients receiving evidence based therapies to reduce cardiovascular risk | DOMAIN 2: Cholesterol control | Baseline |
| Percentage of patients receiving evidence based therapies to reduce cardiovascular risk | DOMAIN 3: Blood pressure control | Baseline |
| Percentage of patients receiving evidence based therapies to reduce cardiovascular risk | DOMAIN 4: Glycemic control / diabetes treatment | Baseline |
| Percentage of patients receiving evidence based therapies to reduce cardiovascular risk | DOMAIN 5: Weight control | Baseline |
| Percentage of patients receiving evidence based therapies to reduce cardiovascular risk | DOMAIN 6: Non-pharmacological intervention: In this domain, there are 2 items to be evaluated: 1) No smoking; 2) Physical exercise ≥ 150 minutes per week. | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of patients receiving complete evidence based therapies to reduce cardiovascular risk | Patient should receive all of the following to consider complete evidence based therapy: Appropriate use of antithrombotic therapy; Cholesterol control; Blood pressure control; Glycemic control / diabetes treatment; Weight control; Non-pharmacological intervention | 6 and 12 months |
Not provided
Inclusion Criteria:
Patients ≥45 years followed in ambulatory setting with ≥1 of the following 3 criteria:
Documented coronary disease (≥1 criteria must apply):
Documented symptomatic Peripheral Arterial Disease (≥1 criteria must apply):
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with coronary and peripheral arterial disease in an outpatient setting
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pedro de Barros e Silva, MD, MHS, PhD | Faculty | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Do Coração | São Paulo | São Paulo | 05410001 | Brazil |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38378735 | Derived | de Barros E Silva PGM, do Nascimento CT, Pedrosa RP, Nakazone MA, do Nascimento MU, de Araujo Melo L, Junior OLS, Zimmermann SL, de Melo RMV, Bergo RR, Precoma DB, Tramujas L, Lima EG, Dantas JMM, do Amaral Baruzzi AC, Flumignan RLG, de Oliveira Paiva MSM, Gowdak LHW, de Carvalho PN, de Figueiredo Neto JA, Silvestre OM, Fioranelli A, Vieira RD', Horak ACP, Miyada DHK, Kojima FCS, de Oliveira JS, de Oliveira Silva L, Pavanello R, Ramacciotti E, Lopes RD; NEAT Investigators. Primary results of the brazilian registry of atherothrombotic disease (NEAT). Sci Rep. 2024 Feb 20;14(1):4222. doi: 10.1038/s41598-024-54516-9. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003324 | Coronary Artery Disease |
| D058729 | Peripheral Arterial Disease |
| D013927 | Thrombosis |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Percentage of patients with complete control of risk factors (blood pressure, cholesterol and glycemia) | blood pressure, cholesterol and glycemia levels at baseline, 06 and 12 months | baseline, 06 and 12 months |
| D001161 |
| Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
| D050197 | Atherosclerosis |
| D016491 | Peripheral Vascular Diseases |
| D016769 | Embolism and Thrombosis |